Context Therapeutics (NASDAQ: CNTX)

Last close As at 19/04/2024

1.22

0.00 (0.00%)

Market capitalisation

USD19m

Latest Insights

View More
Doctor with cancer patient

Balance Sheet

Forecast net debt (US$m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 119.1 79.4 (38.7)
Relative 106.7 60.8 (47.6)
52 week high/low US$2.3/US$0.5

Financials

Edison Investment Research is terminating coverage on Context Therapeutics (CNTX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Y/E Dec Revenue (US$m) EBITDA (US$m) PBT (US$m) EPS (fd) (c) P/E (x) P/CF (x)
2021A 0.0 (10.5) (10.6) (373.72) N/A N/A
2022A 0.0 (15.4) (14.8) (93.00) N/A N/A
2023E N/A N/A N/A N/A N/A N/A
2024E N/A N/A N/A N/A N/A N/A